Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Times Interest Earned (2016 - 2017)

Heron Therapeutics (HRTX) has disclosed Times Interest Earned for 3 consecutive years, with -$59.79 as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Times Interest Earned changed N/A year-over-year to -$59.79, compared with a TTM value of -$120.68 through Sep 2017, changed N/A, and an annual FY2025 reading of -$0.26, up 86.17% over the prior year.
  • Times Interest Earned was -$59.79 for Q4 2016 at Heron Therapeutics, up from -$60.59 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$23.61 in Q1 2012 and bottomed at -$179.61 in Q1 2013.
  • Average Times Interest Earned over 3 years is -$79.56, with a median of -$60.59 recorded in 2013.
  • Peak annual rise in Times Interest Earned hit 660.75% in 2013, while the deepest fall reached 660.75% in 2013.
  • Year by year, Times Interest Earned stood at -$23.61 in 2012, then tumbled by 156.65% to -$60.59 in 2013, then increased by 1.32% to -$59.79 in 2016.
  • Business Quant data shows Times Interest Earned for HRTX at -$59.79 in Q4 2016, -$60.59 in Q3 2013, and -$74.19 in Q2 2013.